Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q2 EPS by 17c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q2 EPS of ($0.37), $0.17 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance